Metabolic

Sexual dimorphism in COVID-19: potential clinical and public health implications

  • 1.
    • Grabek A
    • Dolfi B
    • Klein B
    • Jian-Motamedi F
    • Chaboissier MC
    • Schedl A

    The adult adrenal cortex undergoes rapid tissue renewal in a sex-specific manner.

    Cell Stem Cell. 2019; 25: 290-296.e2

  • 2.

    Sexual dimorphism in immunometabolism and autoimmunity: impact on personalized medicine.

    Autoimmun Rev. 2021; 20102775

  • 3.

    Sex-specific differences in hypertension and associated cardiovascular disease.

    Nat Rev Nephrol. 2018; 14: 185-201

  • 4.
    • Alwani M
    • Yassin A
    • Al-Zoubi RM
    • et al.

    Sex-based differences in severity and mortality in COVID-19.

    Rev Med Virol. 2021; 31e2223

  • 5.
    • Chen N
    • Zhou M
    • Dong X
    • et al.

    Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

    Lancet. 2020; 395: 507-513

  • 6.
    • Zhao S
    • Cao P
    • Chong MKC
    • et al.

    COVID-19 and gender-specific difference: analysis of public surveillance data in Hong Kong and Shenzhen, China, from January 10 to February 15, 2020.

    Infect Control Hosp Epidemiol. 2020; 41: 750-751

  • 7.

    The sex, gender and COVID-19 project.

  • 8.
    • Geldsetzer P
    • Mukama T
    • Jawad N
    • Riffe T
    • Rogers A
    • Sudharsanan N

    Sex differences in the mortality rate for coronavirus disease 2019 compared to other causes of death.

    medRxiv. 2021; ()

  • 9.
    • Chakravarty D
    • Nair SS
    • Hammouda N
    • et al.

    Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer.

    Commun Biol. 2020; 3: 374

  • 10.

    Sex differences for fasting levels of glucose and insulin: expanding our understanding.

    Nat Rev Endocrinol. 2021; 17: 131

  • 11.
    • Lagou V
    • Mägi R
    • Hottenga J-J
    • et al.

    Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability.

    Nat Commun. 2021; 12: 1-18

  • 12.
    • Tramunt B
    • Smati S
    • Coudol S
    • et al.

    Sex disparities in COVID-19 outcomes of inpatients with diabetes: insights from the CORONADO study.

    Eur J Endocrinol. 2021; 185: 299-311

  • 13.
    • McGurnaghan SJ
    • Weir A
    • Bishop J
    • et al.

    Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland.

    Lancet Diabetes Endocrinol. 2021; 9: 82-93

  • 14.
    • Iorga A
    • Cunningham CM
    • Moazeni S
    • Ruffenach G
    • Umar S
    • Eghbali M

    The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy.

    Biol Sex Differ. 2017; 8: 33

  • 15.
    • Veldhuis JD
    • Sharma A
    • Roelfsema F

    Age-dependent and gender-dependent regulation of hypothalamic-adrenocorticotropic-adrenal axis.

    Endocrinol Metab Clin North Am. 2013; 42: 201-225

  • 16.
    • Amur S
    • Parekh A
    • Mummaneni P

    Sex differences and genomics in autoimmune diseases.

    J Autoimmun. 2012; 38: J254-J265

  • 17.
    • Umiker BR
    • Andersson S
    • Fernandez L
    • et al.

    Dosage of X-linked Toll-like receptor 8 determines gender differences in the development of systemic lupus erythematosus.

    Eur J Immunol. 2014; 44: 1503-1516

  • 18.
    • O’Driscoll DN
    • De Santi C
    • McKiernan PJ
    • McEneaney V
    • Molloy EJ
    • Greene CM

    Expression of X-linked Toll-like receptor 4 signaling genes in female vs. male neonates.

    Pediatr Res. 2017; 81: 831-837

  • 19.
    • Schurz H
    • Salie M
    • Tromp G
    • Hoal EG
    • Kinnear CJ
    • Möller M

    The X chromosome and sex-specific effects in infectious disease susceptibility.

    Hum Genomics. 2019; 13: 2

  • 20.
    • Berghöfer B
    • Frommer T
    • Haley G
    • Fink L
    • Bein G
    • Hackstein H

    TLR7 ligands induce higher IFN-alpha production in females.

    J Immunol. 2006; 177: 2088-2096

  • 21.

    Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.

    Nature. 2020; 581: 215-220

  • 22.
    • Gagliardi MC
    • Tieri P
    • Ortona E
    • Ruggieri A

    ACE2 expression and sex disparity in COVID-19.

    Cell Death Discov. 2020; 6: 37

  • 23.

    X-linked diseases: susceptible females.

    Genet Med. 2020; 22: 1156-1174

  • 24.
    • Karlberg J
    • Chong DS
    • Lai WY

    Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?.

    Am J Epidemiol. 2004; 159: 229-231

  • 25.
    • Barthel A
    • Mohanraj K
    • Biener AM
    • Bornstein SR

    Metabolic syndrome and COVID-19: endocrine-immune vascular interactions shape the clinical course.

    Endocrinology. 2020; 161bqaa131

  • 26.
    • Dotan A
    • Muller S
    • Kanduc D
    • David P
    • Halpert G
    • Shoenfeld Y

    The SARS-CoV-2 as an instrumental trigger of autoimmunity.

    Autoimmun Rev. 2021; 20102792

  • 27.
    • Steenblock C
    • Schwarz PEH
    • Ludwig B
    • et al.

    COVID-19 and metabolic disease: mechanisms and clinical management.

    Lancet Diabetes Endocrinol. 2021; 9: 786-798

  • 28.
    • Elzinga SE
    • Savelieff MG
    • O’Brien PD
    • Mendelson FE
    • Hayes JM
    • Feldman EL

    Sex differences in insulin resistance, but not peripheral neuropathy, in a diet-induced prediabetes mouse model.

    Dis Model Mech. 2021; 14dmm048909

  • 29.
    • Broussard JL
    • Perreault L
    • Macias E
    • et al.

    Sex differences in insulin sensitivity are related to muscle tissue acylcarnitine but not subcellular lipid distribution.

    Obesity (Silver Spring). 2021; 29: 550-561

  • 30.
    • Sheng L
    • Jena PK
    • Hu Y
    • Wan YY

    Age-specific microbiota in altering host inflammatory and metabolic signaling as well as metabolome based on the sex.

    Hepatobiliary Surg Nutr. 2021; 10: 31-48

  • 31.
    • Goossens GH
    • Jocken JWE
    • Blaak EE

    Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver.

    Nat Rev Endocrinol. 2021; 17: 47-66

  • 32.
    • Karere GM
    • Cox LA
    • Bishop AC
    • et al.

    Sex differences in microRNA expression and cardiometabolic risk factors in hispanic adolescents with obesity.

    J Pediatr. 2021; 235: 138-143.e5

  • 33.

    Sex differences in immune responses.

    Nat Rev Immunol. 2016; 16: 626-638

  • 34.

    Obesity as a predictor for a poor prognosis of COVID-19: a systematic review.

    Diabetes Metab Syndr. 2020; 14: 655-659

  • 35.
    • Petersen A
    • Bressem K
    • Albrecht J
    • et al.

    The role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in Germany.

    Metabolism. 2020; 110154317

  • 36.
    • Földi M
    • Farkas N
    • Kiss S
    • et al.

    Visceral adiposity elevates the risk of critical condition in COVID-19: a systematic review and meta-analysis.

    Obesity (Silver Spring). 2021; 29: 521-528

  • 37.
    • Ishikawa A
    • Wada T
    • Nishimura S
    • et al.

    Estrogen regulates sex-specific localization of regulatory T cells in adipose tissue of obese female mice.

    PLoS One. 2020; 15e0230885

  • 38.
    • Camporez JP
    • Lyu K
    • Goldberg EL
    • et al.

    Anti-inflammatory effects of oestrogen mediate the sexual dimorphic response to lipid-induced insulin resistance.

    J Physiol. 2019; 597: 3885-3903

  • 39.
    • Varghese M
    • Griffin C
    • McKernan K
    • et al.

    Sex differences in inflammatory responses to adipose tissue lipolysis in diet-induced obesity.

    Endocrinology. 2019; 160: 293-312

  • 40.
    • Takahashi T
    • Ellingson MK
    • Wong P
    • et al.

    Sex differences in immune responses that underlie COVID-19 disease outcomes.

    Nature. 2020; 588: 315-320

  • 41.
    • Chen Y
    • Klein SL
    • Garibaldi BT
    • et al.

    Aging in COVID-19: vulnerability, immunity and intervention.

    Ageing Res Rev. 2021; 65101205

  • 42.
    • Márquez EJ
    • Chung CH
    • Marches R
    • et al.

    Sexual-dimorphism in human immune system aging.

    Nat Commun. 2020; 11: 751

  • 43.

    The physiological mechanisms of the sex-based difference in outcomes of COVID19 infection.

    Front Physiol. 2021; 12627260

  • 44.
    • Mauvais-Jarvis F
    • Klein SL
    • Levin ER

    Estradiol, progesterone, immunomodulation, and COVID-19 outcomes.

    Endocrinology. 2020; 161bqaa127

  • 45.

    Estradiol induced alterations of the immune system–I. Enhancement of IgM production.

    Int J Immunopharmacol. 1985; 7: 207-213

  • 46.
    • Qi F
    • Qian S
    • Zhang S
    • Zhang Z

    Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses.

    Biochem Biophys Res Commun. 2020; 526: 135-140

  • 47.
    • Subbarayan K
    • Ulagappan K
    • Wickenhauser C
    • Bachmann M
    • Seliger B

    Immune interaction map of human SARS-CoV-2 target genes: implications for therapeutic avenues.

    Front Immunol. 2021; 12597399

  • 48.

    Dipeptidyl peptidase 4 (DPP4) inhibitor and outcome from coronavirus disease 2019 (COVID-19) in diabetic patients: a systematic review, meta-analysis, and meta-regression.

    J Diabetes Metab Disord. 2021; 20: 1-8

  • 49.
    • Khunti K
    • Knighton P
    • Zaccardi F
    • et al.

    Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England.

    Lancet Diabetes Endocrinol. 2021; 9: 293-303

  • 50.

    DPP-4 inhibitors may improve the mortality of coronavirus disease 2019: a meta-analysis.

    PLoS One. 2021; 16e0251916

  • 51.
    • Abuhasira R
    • Ayalon-Dangur I
    • Zaslavsky N
    • et al.

    A randomized clinical trial of linagliptin vs. standard of care in patients hospitalized with diabetes and COVID-19.

    Front Endocrinol. 2021; 12794382

  • 52.
    • Ohta N
    • Takahashi T
    • Mori T
    • et al.

    Hormonal modulation of prolyl endopeptidase and dipeptidyl peptidase IV activities in the mouse uterus and ovary.

    Acta Endocrinol (Copenh). 1992; 127: 262-266

  • 53.
    • Rajput MS
    • Sarkar PD
    • Nirmal NP

    Inhibition of DPP-4 activity and neuronal atrophy with genistein attenuates neurological deficits induced by transient global cerebral ischemia and reperfusion in streptozotocin-induced diabetic mice.

    Inflammation. 2017; 40: 623-635

  • 54.
    • Abdalla MA
    • Deshmukh H
    • Atkin S
    • Sathyapalan T

    The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence.

    Ther Adv Endocrinol Metab. 2021; 12 ()

  • 55.
    • Kim SC
    • Schneeweiss S
    • Glynn RJ
    • Doherty M
    • Goldfine AB
    • Solomon DH

    Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study.

    Ann Rheum Dis. 2015; 74: 1968-1975

  • 56.
    • Yazbeck R
    • Jaenisch SE
    • Abbott CA

    Dipeptidyl peptidase 4 inhibitors: applications in innate immunity?.

    Biochem Pharmacol. 2021; 188114517

  • 57.

    Sex differences in immune responses.

    Science. 2021; 371: 347-348

  • 58.
    • Ou T
    • Mou H
    • Zhang L
    • Ojha A
    • Choe H
    • Farzan M

    Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2.

    PLoS Pathog. 2021; 17e1009212

  • 59.
    • Hoffmann M
    • Kleine-Weber H
    • Schroeder S
    • et al.

    SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.

    Cell. 2020; 181: 271-280

  • 60.
    • Schuler BA
    • Habermann AC
    • Plosa EJ
    • et al.

    Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium.

    J Clin Invest. 2021; 131140766

  • 61.
    • Okwan-Duodu D
    • Lim E-C
    • You S
    • Engman DM

    TMPRSS2 activity may mediate sex differences in COVID-19 severity.

    Signal Transduct Target Ther. 2021; 6: 100

  • 62.
    • Samuel RM
    • Majd H
    • Richter MN
    • Ghazizadeh Z
    • Zekavat SM
    • Navickas A
    • et al.

    Androgen signaling regulates SARS-CoV-2 receptor levels and is associated with severe COVID-19 symptoms in men.

    Cell Stem Cell. 2020; 27: 876-889

  • 63.
    • Asselta R
    • Paraboschi EM
    • Mantovani A
    • Duga S

    ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy.

    Aging (Albany NY). 2020; 12: 10087-10098

  • 64.
    • Leach DA
    • Mohr A
    • Giotis ES
    • et al.

    The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells.

    Nat Commun. 2021; 124068

  • 65.
    • Gunst JD
    • Staerke NB
    • Pahus MH
    • et al.

    Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19 —a double-blind randomized controlled trial.

    EClinicalMedicine. 2021; 35100849

  • 66.

    Sex differences in the hypothalamic-pituitary-adrenal axis’ response to stress: an important role for gonadal hormones.

    Neuropsychopharmacology. 2019; 44: 45-58

  • 67.

    Gonadal steroid hormones and the hypothalamo-pituitary-adrenal axis.

    Front Neuroendocrinol. 2014; 35: 197-220

  • 68.
    • Kanczkowski W
    • Evert K
    • Stadtmüller M
    • et al.

    COVID-19 targets human adrenal glands.

    Lancet Diabetes Endocrinol. 2021;

  • 69.
    • Horby P
    • Lim WS
    • Emberson JR
    • et al.

    Dexamethasone in hospitalized patients with Covid-19.

    N Engl J Med. 2021; 384: 693-704

  • 70.
    • Águas R
    • Mahdi A
    • Shretta R
    • Horby P
    • Landray M
    • White L

    Potential health and economic impacts of dexamethasone treatment for patients with COVID-19.

    Nat Commun. 2021; 12: 1-8

  • 71.
    • Ranjbar K
    • Moghadami M
    • Mirahmadizadeh A
    • et al.

    Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial.

    BMC Infect Dis. 2021; 21: 1-8

  • 72.
    • Da Pozzo E
    • Giacomelli C
    • Cavallini C
    • Martini C

    Cytokine secretion responsiveness of lymphomonocytes following cortisol cell exposure: sex differences.

    PLoS One. 2018; 13e0200924

  • 73.
    • Ghandehari S
    • Matusov Y
    • Pepkowitz S
    • et al.

    Progesterone in addition to standard of care vs standard of care alone in the treatment of men hospitalized with moderate to severe COVID-19: a randomized, controlled pilot trial.

    Chest. 2021; 160: 74-84

  • 74.
    • Montopoli M
    • Zumerle S
    • Vettor R
    • et al.

    Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).

    Ann Oncol. 2020; 31: 1040-1045

  • 75.
    • Goren A
    • Wambier CG
    • Herrera S
    • et al.

    Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men.

    J Eur Acad Dermatol Venereol. 2021; 35: e13-e15

  • 76.
    • Dambha-Miller H
    • Hinton W
    • Joy M
    • Feher M
    • de Lusignan S

    Mortality in COVID-19 amongst women on hormone replacement therapy or combined oral contraception: a cohort study.

    medRxiv. 2021; ()

  • 77.

    Menopause transition: a golden age to prevent cardiovascular disease.

    Lancet Diabetes Endocrinol. 2021; 9: 135-137

  • 78.
    • Okpechi SC
    • Fong JT
    • Gill SS
    • et al.

    Global sex disparity of COVID-19: a descriptive review of sex hormones and consideration for the potential therapeutic use of hormone replacement therapy in older adults.

    Aging Dis. 2021; 12: 671-683

  • 79.
    • Rastrelli G
    • Di Stasi V
    • Inglese F
    • et al.

    Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients.

    Andrology. 2021; 9: 88-98

  • 80.
    • Dhindsa S
    • Zhang N
    • McPhaul MJ
    • et al.

    Association of circulating sex hormones with inflammation and disease severity in patients with COVID-19.

    JAMA Netw Open. 2021; 4e2111398

  • 81.
    • Mohamad N-V
    • Wong SK
    • Hasan WNW
    • et al.

    The relationship between circulating testosterone and inflammatory cytokines in men.

    Aging Male. 2018;

  • 82.
    • Wu Y-H
    • Tseng C-P
    • Cheng M-L
    • Ho H-Y
    • Shih S-R
    • Chiu DT-Y

    Glucose-6-phosphate dehydrogenase deficiency enhances human coronavirus 229E infection.

    J Infect Dis. 2008; 197: 812-816

  • 83.
    • Ackermann M
    • Verleden SE
    • Kuehnel M
    • et al.

    Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19.

    N Engl J Med. 2020; 383: 120-128

  • 84.
    • Heymann AD
    • Cohen Y
    • Chodick G

    Glucose-6-phosphate dehydrogenase deficiency and type 2 diabetes.

    Diabetes care. 2012; 35: e58

  • 85.

    Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19.

    Endocr Relat Cancer. 2021; 28: R47-R53

  • 86.
    • Di Toro F
    • Gjoka M
    • Di Lorenzo G
    • et al.

    Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis.

    Clin Microbiol Infect. 2021; 27: 36-46

  • 87.
    • Ellington S
    • Strid P
    • Tong VT
    • et al.

    Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status—United States, January 22–June 7, 2020.

    MMWR Morb Mortal Wkly Rep. 2020; 69: 769-775

  • 88.
    • Knight M
    • Bunch K
    • Vousden N
    • et al.

    Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study.

    BMJ. 2020; 369m2107

  • 89.
    • Wastnedge EAN
    • Reynolds RM
    • van Boeckel SR
    • et al.

    Pregnancy and COVID-19.

    Physiol Rev. 2021; 101: 303-318

  • 90.
    • Adrielle Dos Santos L
    • Filho PGG
    • Silva AMF
    • et al.

    Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers.

    J Infect. 2021; 82: 399-406

  • 91.
    • Abdelrahman MM
    • Abd-Elrahman NM
    • Bakheet TM

    Persistence of symptoms after improvement of acute COVID19 infection, a longitudinal study.

    J Med Virol. 2021; 93: 5942-5946

  • 92.
    • Klein SL
    • Pekosz A
    • Park H-S
    • et al.

    Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population.

    J Clin Invest. 2020; 130: 6141-6150

  • 93.
    • Galasso V
    • Pons V
    • Profeta P
    • Becher M
    • Brouard S
    • Foucault M

    Gender differences in COVID-19 attitudes and behavior: panel evidence from eight countries.

    Proc Natl Acad Sci USA. 2020; 117: 27285-27291

  • 94.
    • Reisch T
    • Heiler G
    • Hurt J
    • Klimek P
    • Hanbury A
    • Thurner S

    Behavioral gender differences are reinforced during the COVID-19 crisis.

    Sci Rep. 2021; 1119241

  • 95.

    What reinfections mean for COVID-19.

    Lancet Infect Dis. 2021; 21: 3-5

  • 96.
    • Van Elslande J
    • Vermeersch P
    • Vandervoort K
    • et al.

    Symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection by a phylogenetically distinct strain.

    Clin Infect Dis. 2021; 73: 354-356

  • 97.
    • Pulliam JR
    • van Schalkwyk C
    • Govender N
    • et al.

    Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa.

    medRxiv. 2021; ()

  • 98.

    How bad is Omicron? What scientists know so far.

    Nature. 2021; 600: 197-199

  • 99.
    • Cavanaugh AM
    • Spicer KB
    • Thoroughman D
    • Glick C
    • Winter K

    Reduced risk of reinfection with SARS-CoV-2 after COVID-19 vaccination—Kentucky, May–June 2021.

    MMWR Morb Mortal Wkly Rep. 2021; 70: 1081-1083

  • 100.
    • Klein SL
    • Jedlicka A
    • Pekosz A

    The Xs and Y of immune responses to viral vaccines.

    Lancet Infect Dis. 2010; 10: 338-349

  • 101.
    • Muir K-L
    • Kallam A
    • Koepsell SA
    • Gundabolu K

    Thrombotic thrombocytopenia after Ad26. COV2. S vaccination.

    N Engl J Med. 2021; 384: 1964-1965

  • 102.
    • Greinacher A
    • Thiele T
    • Warkentin TE
    • Weisser K
    • Kyrle PA
    • Eichinger S

    Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination.

    N Engl J Med. 2021; 384: 2092-2101

  • 103.

    SARS-CoV-2 Vaccine-induced immune thrombotic thrombocytopenia.

    N Engl J Med. 2021; 384: 2254-2256

  • 104.
    • Shay DK
    • Shimabukuro TT
    • DeStefano F

    Myocarditis occurring after immunization with mRNA-based COVID-19 vaccines.

    JAMA Cardiol. 2021; 6: 1115-1117

  • 105.
    • Rosenblum HG
    • Hadler SC
    • Moulia D
    • et al.

    Use of COVID-19 vaccines after reports of adverse events among adult recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna): update from the Advisory Committee on Immunization Practices—United States, July 2021.

    MMWR Morb Mortal Wkly Rep. 2021; 70: 1094-1099

  • 106.
    • Hacisuleyman E
    • Hale C
    • Saito Y
    • et al.

    Vaccine breakthrough infections with SARS-CoV-2 variants.

    N Engl J Med. 2021; 384: 2212-2218

  • 107.
    • CDC COVID-19 Vaccine Breakthrough Case Investigations Team

    COVID-19 vaccine breakthrough infections reported to CDC—United States, January 1–April 30, 2021.

    MMWR Morb Mortal Wkly Rep. 2021; 70: 792-793

  • 108.
    • Huang C
    • Huang L
    • Wang Y
    • et al.

    6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.

    Lancet. 2021; 397: 220-232

  • 109.
    • Ortega-Hernandez OD
    • Shoenfeld Y

    Infection, vaccination, and autoantibodies in chronic fatigue syndrome, cause or coincidence?.

    Ann N Y Acad Sci. 2009; 1173: 600-609

  • 110.
    • Appel S
    • Chapman J
    • Shoenfeld Y

    Infection and vaccination in chronic fatigue syndrome: myth or reality?.

    Autoimmunity. 2007; 40: 48-53

  • 111.

    Immune determinants of COVID-19 disease presentation and severity.

    Nat Med. 2021; 27: 28-33

  • 112.
    • Seeßle J
    • Waterboer T
    • Hippchen T
    • et al.

    Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study.

    Clin Infect Dis. 2021; ciab611

  • 113.
    • Gebhard CE
    • Suetsch C
    • Bengs S
    • et al.

    Sex-and gender-specific risk factors of post-COVID-19 syndrome: a population-based cohort study in Switzerland.

    medRxiv. 2021; ()

  • 114.
    • Sudre CH
    • Murray B
    • Varsavsky T
    • et al.

    Attributes and predictors of long COVID.

    Nat Med. 2021; 27: 626-631

  • 115.
    • Hoffman KW
    • Lee JJ
    • Foster GA
    • Krysztof D
    • Stramer SL
    • Lim JK

    Sex differences in cytokine production following West Nile virus infection: Implications for symptom manifestation.

    Pathog Dis. 2019; 77ftz016

  • 116.
    • Pandey JP
    • Fudenberg HH
    • Ainsworth SK
    • Loadholt CB

    Autoantibodies in healthy subjects of different age groups.

    Mech Ageing Dev. 1979; 10: 399-404

  • 117.
    • Williams AJ
    • Norcross AJ
    • Dix RJ
    • Gillespie KM
    • Gale EA
    • Bingley PJ

    The prevalence of insulin autoantibodies at the onset of type 1 diabetes is higher in males than females during adolescence.

    Diabetologia. 2003; 46: 1354-1356

  • 118.

    Rogue antibodies could be driving severe COVID-19.

    Nature. 2021; 590: 29-31

  • 119.
    • Bornstein SR
    • Voit-Bak K
    • Donate T
    • et al.

    Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis?.

    Mol Psychiatry. 2021; ()

  • 120.
    • Leynaert B
    • Sunyer J
    • Garcia-Esteban R
    • et al.

    Gender differences in prevalence, diagnosis and incidence of allergic and non-allergic asthma: a population-based cohort.

    Thorax. 2012; 67: 625-631

  • 121.
    • Maccio U
    • Zinkernagel AS
    • Shambat SM
    • et al.

    SARS-CoV-2 leads to a small vessel endotheliitis in the heart.

    EBioMedicine. 2021; 63103182

  • Related Articles